Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris-Reference-Cited by-同舟云学术

Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris

Published:2009-09 Issue:9 Volume:129 Page:2202-2210
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Nagel Angela,Podstawa Eva,Eickmann Markus,Müller Hans-Helge,Hertl Michael,Eming Rüdiger

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference47 articles.

1. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment;Ahmed;J Am Acad Dermatol,2001

2. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin;Ahmed;N Engl J Med,2006

3. Autoimmunity against desmosomal cadherins in pemphigus;Amagai;J Dermatol Sci,1999

4. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris;Asashima;Br J Dermatol,2006

5. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells;Avery;J Clin Invest,2003

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges;International Immunopharmacology;2024-10

2. Off-Label Uses of Rituximab in Dermatology;Current Dermatology Reports;2022-10-06

3. Dual B-cell targeting therapy ameliorates autoimmune cholangitis;Journal of Autoimmunity;2022-10

4. FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus;Frontiers in Immunology;2022-05-18

5. Rituximab Therapy for Primary Sjögren’s Syndrome;Frontiers in Pharmacology;2021-09-02